Tislelizumab Under Review for Esophageal Squamous Cell Carcinoma
The application is supported by data from the phase 3 RATIONALE 302 trial.
Esophageal Cancer
Esophageal and Esophagogastric Junction Cancer Treatment Regimens
Find the latest cancer treatment regimens for esophageal and esophagogastric junction cancers, including drugs such as ECF, cisplatin, and 5-FU.
Perioperative Chemotherapy Matches Neoadjuvant Multimodal Therapy for Esophageal Cancer
Researchers found that CROSS is not inferior to MAGIC/FLOT, supporting it’s place in decision making for patients with locally advanced esophageal cancer.
Immunotherapy, Chemotherapy Combination Improves Survival in Advanced Esophageal Cancer
Researchers have identified a potentially new first-line treatment option for patients with advanced or metastatic esophageal squamous cell carcinoma.
Update Supports Adjuvant Nivolumab as Standard Care in Resected Esophageal or Gastroesophageal Junction Cancer
Adjuvant nivolumab prolonged distant metastasis-free survival.
Early Interdisciplinary Supportive Care Beneficial in Metastatic Esophagogastric Cancer
Researchers sought to determine the effects of providing early interdisciplinary care on overall survival, progression-free survival, and adverse events in previously untreated patients with esophagogastric cancer.
Trends in Age-Based Incidence of Esophageal Adenocarcinoma Over Time
Population-based analysis identified trends in incidence and disease-free survival for patients with advanced-stage carcinoma across 3 age groups.
Genomic Instability Predicts Risk of Progression for Barrett Esophagus
Genomic copy number instability predicted the risk of disease progression among patients with Barrett esophagus years beforehand.
Periodontal Disease, Tooth Loss Linked to Esophageal, Gastric Cancer
Prospective study shows increased risk for esophageal, gastric adenocarcinoma in two large cohorts.
Early-Onset, Severe Cardiac Toxicity Common in Locoregional Esophageal Cancer Treated with Radiotherapy
Findings from a recent study support pretreatment screening for heart disease in patients with newly diagnosed, locoregional esophageal cancer.
- Loading...
Loading...
Next post in Gastrointestinal Cancer
Loading... 
Loading...